# Trial of Sirolimus for Cognitive Impairment in Sturge-Weber Syndrome

> **NCT03047980** · PHASE2,PHASE3 · COMPLETED · sponsor: **Anne Comi, MD** · enrollment: 10 (actual)

## Conditions studied

- Sturge-Weber Syndrome

## Interventions

- **DRUG:** Sirolimus

## Key facts

- **NCT ID:** NCT03047980
- **Lead sponsor:** Anne Comi, MD
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01
- **Primary completion:** 2019-06-04
- **Final completion:** 2020-10-27
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2021-11-01

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03047980

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03047980, "Trial of Sirolimus for Cognitive Impairment in Sturge-Weber Syndrome". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03047980. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*